NVS Novartis AG PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: NVS
- PE Ratio
As of Jul 8, 2025, the Novartis AG stock's PE ratio is 18.89. This results from the current EPS of $6.44 and stock price of $121.68. The PE ratio has increased by 25% from the past four quarters average of 15.2.
NVS PE ratio history
The PE ratio of Novartis AG has averaged 19.98 over the last ten years. The current price-to-earnings ratio of 18.89 is 5% less than the historical average. In the past ten years, NVS's PE ratio reached its highest point in the Jun 2017 quarter at 30.35, when the stock price was $83.47 and the EPS was $2.75. The lowest point was recorded in the Sep 2022 quarter, when it reached 7.77 with a price of $76.01 and an EPS of $9.78.
Novartis AG PE ratio by year
Maximum annual increase: 248.1% in 2022
Maximum annual decrease: -69.29% in 2021
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 16.44 | 16.43% | $97.31 | $5.92 |
| 2023 | 14.12 | -50.35% | $100.97 | $7.15 |
| 2022 | 28.44 | 248.1% | $90.72 | $3.19 |
| 2021 | 8.17 | -69.29% | $87.47 | $10.71 |
| 2020 | 26.6 | 43.86% | $94.43 | $3.55 |
| 2019 | 18.49 | 17.25% | $94.69 | $5.12 |
| 2018 | 15.77 | -38.4% | $85.81 | $5.44 |
| 2017 | 25.6 | -0.89% | $83.96 | $3.28 |
| 2016 | 25.83 | 122.1% | $72.84 | $2.82 |
| 2015 | 11.63 | -47.16% | $86.04 | $7.4 |
| 2014 | 22.01 | 2.95% | $92.66 | $4.21 |
| 2013 | 21.38 | 29.34% | $80.38 | $3.76 |
| 2012 | 16.53 | 8.39% | $63.3 | $3.83 |
| 2011 | 15.25 | 10.75% | $57.17 | $3.75 |
| 2010 | 13.77 | -6.39% | $58.95 | $4.28 |
Novartis AG PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 17.31 | 5.29% | $111.48 | $6.44 |
| Dec 2024 | 16.44 | 22.78% | $97.31 | $5.92 |
| Sep 2024 | 13.39 | -1.11% | $115.02 | $8.59 |
| Jun 2024 | 13.54 | 3.2% | $106.46 | $7.86 |
| Mar 2024 | 13.12 | -7.08% | $96.73 | $7.37 |
| Dec 2023 | 14.12 | -48.16% | $100.97 | $7.15 |
| Sep 2023 | 27.24 | -2.3% | $101.86 | $3.74 |
| Jun 2023 | 27.88 | -0.61% | $100.91 | $3.62 |
| Mar 2023 | 28.05 | -1.37% | $92 | $3.28 |
| Dec 2022 | 28.44 | 266.02% | $90.72 | $3.19 |
| Sep 2022 | 7.77 | -5.47% | $76.01 | $9.78 |
| Jun 2022 | 8.22 | 1.11% | $84.53 | $10.28 |
| Mar 2022 | 8.13 | -0.49% | $87.75 | $10.8 |
| Dec 2021 | 8.17 | -56.45% | $87.47 | $10.71 |
| Sep 2021 | 18.76 | -18.15% | $81.78 | $4.36 |
NVS Price vs fair value
NVS average PE ratio chart
The current PE ratio of NVS is above its 3 and 5-year historical averages, but it is lower than the 10-year average.
NVS PE vs peers
NVS's PE ratio is less than its peer stock AZN, but it is above JNJ's and ABT's. Novartis AG's current PE ratio of 18.89 is more than the average of its peers, which is 18.36.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MRK Merck & Co Inc | 11.81 | $204.32B |
| JNJ Johnson & Johnson | 17.2 | $374.84B |
| ABT Abbott Laboratories | 17.27 | $232.02B |
| BMY Bristol Myers Squibb Co | 17.55 | $95.73B |
| PFE Pfizer Inc | 18.43 | $145.66B |
| NVS Novartis AG | 18.89 | $238.41B |
| AZN Astrazeneca plc | 27.9 | $217.06B |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $19.07B |
Frequently asked questions
What is Novartis AG's PE ratio?
NVS stock has a price to earnings ratio of 18.89 as of Jul 8, 2025.
What is the 3-year average PE ratio for Novartis AG (NVS)?
The 3-year average PE ratio for NVS stock is 18.85.
What is the 5-year average PE ratio for Novartis AG (NVS)?
The 5-year average PE ratio for NVS stock is 18.54.
What is the highest PE ratio for NVS?
Over the last ten years, the quarterly PE ratio reached a historic high of 30.35 in the Jun 2017 quarter.
How does the current PE ratio for NVS compare to its historical average?
NVS's price to earnings ratio is currently 5% below its 10-year historical average.
How is NVS's PE ratio calculated (Novartis AG PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Jul 8, 2025), Novartis AG's stock price is $121.68. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $6.44. Therefore, Novartis AG's price to earnings ratio for today is 18.89. PE RATIO(18.89) = STOCK PRICE($121.68) / TTM EPS($6.44)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.